These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29196825)

  • 1. Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments.
    Pazan F; Burkhardt H; Frohnhofen H; Weiss C; Throm C; Kuhn-Thiel A; Wehling M
    Eur J Clin Pharmacol; 2018 Mar; 74(3):339-347. PubMed ID: 29196825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification.
    Wehling M; Burkhardt H; Kuhn-Thiel A; Pazan F; Throm C; Weiss C; Frohnhofen H
    Age Ageing; 2016 Mar; 45(2):262-7. PubMed ID: 26786346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FORTA (Fit fOR The Aged)-EPI (Epidemiological) Algorithm: Application of an Information Technology Tool for the Epidemiological Assessment of Drug Treatment in Older People.
    Rabenberg A; Schulte T; Hildebrandt H; Wehling M
    Drugs Aging; 2019 Oct; 36(10):969-978. PubMed ID: 31435913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The FORTA (Fit fOR The Aged) List].
    Pazan F; Wehling M
    Inn Med (Heidelb); 2024 Jan; 65(1):3-8. PubMed ID: 38063911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of "Fit fOR The Aged" (FORTA) on pharmacotherapy and clinical endpoints--a pilot randomized controlled study.
    Michalek C; Wehling M; Schlitzer J; Frohnhofen H
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1261-7. PubMed ID: 25128076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polypharmacy in the elderly - choosing wisely by using the FORTA list].
    Wehling M; Throm C
    Dtsch Med Wochenschr; 2015 Sep; 140(18):1378-82. PubMed ID: 26360952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People.
    Pazan F; Weiss C; Wehling M;
    Drugs Aging; 2018 Jan; 35(1):61-71. PubMed ID: 29335932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
    Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
    Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially inappropriate medications according to PRISCUS list and FORTA (Fit fOR The Aged) classification in geriatric psychiatry: a cross-sectional study.
    Schulze Westhoff M; Groh A; Schröder S; Proskynitopoulos PJ; Jahn K; Klietz M; Krichevsky B; Stichtenoth DO; Wedegärtner F; Bleich S; Frieling H; Heck J
    J Neural Transm (Vienna); 2022 Nov; 129(11):1367-1375. PubMed ID: 36050603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly.
    Kuhn-Thiel AM; Weiß C; Wehling M;
    Drugs Aging; 2014 Feb; 31(2):131-40. PubMed ID: 24353033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
    Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
    Trials; 2016 Jan; 17():57. PubMed ID: 26822311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults.
    Pazan F; Gercke Y; Weiss C; Wehling M;
    J Am Med Dir Assoc; 2020 Mar; 21(3):439.e9-439.e13. PubMed ID: 31542300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA Trial.
    Pazan F; Burkhardt H; Frohnhofen H; Weiss C; Throm C; Kuhn-Thiel A; Wehling M
    Drugs Aging; 2019 Mar; 36(3):269-277. PubMed ID: 30578459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially inappropriate medication among people with dementia in eight European countries.
    Renom-Guiteras A; Thürmann PA; Miralles R; Klaaßen-Mielke R; Thiem U; Stephan A; Bleijlevens MHC; Jolley D; Leino-Kilpi H; Rahm Hallberg I; Saks K; Soto-Martin M; Zabalegui A; Meyer G;
    Age Ageing; 2018 Jan; 47(1):68-74. PubMed ID: 28985257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FORTA(Fit-fOR-The-Aged)-based medication optimization: retrospective analysis of experiences from an unconventional outpatient service.
    Rieg S; Wehling M
    Eur Geriatr Med; 2020 Dec; 11(6):1035-1041. PubMed ID: 32772258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol of the optimal study: Optimization of polypharmacy in geriatric oncology - A randomized controlled trial.
    Schöttker B; Chen LJ; Caspari R; Brenner H
    BMC Cancer; 2023 Apr; 23(1):357. PubMed ID: 37072729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults.
    Pazan F; Gercke Y; Weiss C; Wehling M;
    Arch Gerontol Geriatr; 2020; 91():104217. PubMed ID: 32791361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy Reduction Strategies: Tips on Incorporating American Geriatrics Society Beers and Screening Tool of Older People's Prescriptions Criteria.
    Levy HB
    Clin Geriatr Med; 2017 May; 33(2):177-187. PubMed ID: 28364990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.